Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Among authors: vanagunas a. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ. Fernandez HH, et al. Among authors: vanagunas ad. Mov Disord. 2018 Jul;33(6):928-936. doi: 10.1002/mds.27338. Epub 2018 Mar 23. Mov Disord. 2018. PMID: 29570853 Clinical Trial.
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.
Fernandez HH, Vanagunas A, Odin P, Espay AJ, Hauser RA, Standaert DG, Chatamra K, Benesh J, Pritchett Y, Hass SL, Lenz RA. Fernandez HH, et al. Among authors: vanagunas a. Parkinsonism Relat Disord. 2013 Mar;19(3):339-45. doi: 10.1016/j.parkreldis.2012.11.020. Epub 2013 Jan 1. Parkinsonism Relat Disord. 2013. PMID: 23287001 Free PMC article. Clinical Trial.
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease.
Epstein M, Johnson DA, Hawes R, Schmulewitz N, Vanagunas AD, Gossen ER, Robieson WZ, Eaton S, Dubow J, Chatamra K, Benesh J. Epstein M, et al. Among authors: vanagunas ad. Clin Transl Gastroenterol. 2016 Mar 31;7(3):e159. doi: 10.1038/ctg.2016.19. Clin Transl Gastroenterol. 2016. PMID: 27030949 Free PMC article.
Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats.
Burack M, Aldred J, Zadikoff C, Vanagunas A, Klos K, Bilir B, Fernandez HH, Standaert DG. Burack M, et al. Among authors: vanagunas a. Mov Disord Clin Pract. 2019 Mar 27;6(4):336-337. doi: 10.1002/mdc3.12738. eCollection 2019 Apr. Mov Disord Clin Pract. 2019. PMID: 31061847 Free PMC article. No abstract available.
Patient anxiety and elective gastrointestinal endoscopy.
Jones MP, Ebert CC, Sloan T, Spanier J, Bansal A, Howden CW, Vanagunas AD. Jones MP, et al. Among authors: vanagunas ad. J Clin Gastroenterol. 2004 Jan;38(1):35-40. doi: 10.1097/00004836-200401000-00009. J Clin Gastroenterol. 2004. PMID: 14679325
36 results